• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Election 2025
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Election 2025
  • Government Shutdown
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Recently, the FDA fast-tracked approval of a vaccine for the influenza strain H5N1, even though there had not yet been reported cases of H5N1, and the vaccine had been subjected to significantly less clinical research than the meningitis B vaccine. (Thinkstock)
    Healthcare

    FDA bureaucracy stifles access to life-saving drugs

    Erik Telford -
    January 23, 2014 5:00 am
    0
    FDA panel again rejects wider use of J&J’s Xarelto
    Healthcare

    FDA panel again rejects wider use of J&J’s Xarelto

    Washington Examiner -
    January 16, 2014 9:38 pm
    0
    Studies show not taking medications as prescribed leads to poorer health, more frequent hospitalization, a higher risk of death and as much as $290 billion annually in increased medical costs. But as any health care provider will tell you, the fact that actually taking a medication as prescribed is in a patient’s best interest does not lead to a patient doing what is in his best interest. (Photo: Thinkstock)
    Op-Eds

    Grandstanding AGs sue to stop drugmaker’s work to insure patients take medicine properly

    Peter Pitts -
    January 14, 2014 5:00 am
    0
    When it comes to biosimilars, we need to be extremely thoughtful about how we set policy relating to these promising medicines and strike a balance that promotes health and safety, rather than forcing a binary response that is driven by profits rather than patients. (Photo: Thinkstock)
    Op-Eds

    FDA must decide if a biosimilar rose by any other name is still a rose

    Peter Pitts -
    December 9, 2013 5:00 am
    0
    Obama donor Jeffrey Kindler, shown here in 2009, was Pfizer's CEO during the Obamacare debate. In a corporate filing, the company justified a salary increase by pointing to his Obamacare lobbying. (AP Photo/Mark Lennihan)
    Columnists

    Obama’s corporatist contraceptive mandate

    Timothy P. Carney -
    November 30, 2013 5:00 am
    0
    Electronic cigarettes give smokers a nicotine fix without the stink, tar, fire or carbon monoxide of real cigarettes, but pharmaceutical companies with competing products would like to curtail the e-cig industry. (Photo: Thinkstock) 
    Columnists

    Big Pharma, not tobacco companies, wages war on electronic cigarettes

    Timothy P. Carney -
    November 19, 2013 5:00 am
    0
    This June 6, 2013 photo shows Dr. Jim Olson, pediatric oncologist at Seattle Children's Hospital and research scientist at the Fred Hutchinson Cancer Research Center in Seattle. (AP Photo/John Lok)
    Healthcare

    Pharma’s windfall: The mining of rare diseases

    ken-armstrong -
    November 11, 2013 5:00 am
    0
    If Big Pharma likes your healthcare plan, you can keep it
    Columnists

    If Big Pharma likes your healthcare plan, you can keep it

    Timothy P. Carney -
    November 1, 2013 4:00 am
    0
    Drug Industry Briefing: 52,500 bought insurance on state exchanges
    Beltway Confidential

    Drug Industry Briefing: 52,500 bought insurance on state exchanges

    Timothy P. Carney -
    October 31, 2013 4:00 am
    0
    (Photo: Thinkstock)
    Beltway Confidential

    How industry captures regulatory agencies: drugmakers and the FDA

    Timothy P. Carney -
    October 7, 2013 4:00 am
    0
    1...153154155Page 154 of 155
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter